Dear Colleagues & Friends - One week ago we announced a collaboration with Enable Injections to develop a proprietary POZ polymer conjugate of apomorphine known as SER-252 to treat advanced Parkinson's disease using the enFuse device. You can find more information at www.enableinjections.com and www.serinatherapeutics.com.
Exciting News: Today, Enable announced a new collaboration with Serina Therapeutics, Inc. to develop a potential enFuse® combination product for advanced Parkinson’s disease. Learn more about how Serina’s investigational apomorphine therapy, in combination with enFuse, has the potential to significantly reduce many of the burdens associated with the current standard of care for Parkinson’s patients. https://bit.ly/3WLyCtB